Abstract: A method of treating Hepatitis C by administering an immune system-potentiating dose of at least one Thymosin or system-potentiating Thymosin fragment to a mammal infected with Hepatitis C virus, which Hepatitis C infection in the mammal is non-responsive to treatment with interferon alone.
Type:
Grant
Filed:
March 5, 1993
Date of Patent:
December 14, 1999
Assignees:
SciClone Pharmaceuticals, Inc., The Board of Governors of Wayne State University
Abstract: Treatment of hepatitis B virus (HBV) infection in a patient by administering to the patient a drug regimen including an antiviral-effective amount of thymosin alpha 1 (T.alpha.1) and an antiviral-effective amount of famciclovir.
Abstract: Compositions and methods of use for treating hepatitis C virus-infected mammals are disclosed. The compositions include one or more thymosins alone or in combination with one or more interferons. Methods of treatment include use of thymosins alone, or together, or sequentially with interferon.
Type:
Grant
Filed:
November 4, 1993
Date of Patent:
December 15, 1998
Assignees:
The Board of Governors of Wayne State University, SciClone Pharmaceuticals Inc.